At risk mental state
At risk mental state is the term used to describe the clinical presentation of those considered at risk of developing psychosis or schizophrenia[1]. It has replaced the term prodrome in reference to emerging symptoms of psychosis, as a prodromal period can not be confirmed unless the emergence of the condition has occurred.
The orginal specialist service for those with subclinical symptoms of psychosis was The Pace Clinic[2] in Melbourne, Australia [3]. Other clinics have since developed around the world [4] [5][6][7].
There has been some considerable development of how the concept can be applied clinically [8] [9] [10] [11].
Assessed during the structured interview developed by PACE [12]
Also see
References
- ^ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. PMID 8782287.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ http://www.orygen.org.au/contentPage.asp?pageCode=ATRISK#paceclin
- ^ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. doi:10.1093/schbul/22.2.283. PMID 8782287.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Broome MR, Woolley JB, Johns LC; et al. (2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID 16171652.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ PRIME
- ^ (COPE)
- ^ Emory University
- ^ Yung AR, Phillips LJ, Yuen HP; et al. (2003). "Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group". Schizophr. Res. 60 (1): 21–32. doi:10.1016/S0920-9964(02)00167-6. PMID 12505135.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ McGorry PD, Yung AR, Phillips LJ; et al. (2002). "Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms". Arch. Gen. Psychiatry. 59 (10): 921–8. doi:10.1001/archpsyc.59.10.921. PMID 12365879.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Morrison AP, French P, Parker S; et al. (2007). "Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk". Schizophr Bull. 33 (3): 682–7. doi:10.1093/schbul/sbl042. PMC 2526150. PMID 16973786.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Schäfer Amminger, Papageorgiou Harrigan, Cotton McGorry, Berger (2008). "Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial". Schizophrenia Research. 102: 252.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Yung AR, Yuen HP, McGorry PD; et al. (2005). "Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States". Aust N Z J Psychiatry. 39 (11–12): 964–71. doi:10.1111/j.1440-1614.2005.01714.x. PMID 16343296.
{{cite journal}}: Explicit use of et al. in:|author=(help)CS1 maint: multiple names: authors list (link)
 | This medical symptom article is a stub. You can help Wikipedia by expanding it. |